Lanoxin

Digoxin, the active ingredient in Lanoxin, is a cardiac glycoside presented as an injectable solution for intravenous use. It enhances myocardial contractility and exerts vagomimetic effects, thereby improving cardiac output in heart failure and controlling ventricular response in atrial fibrillation and related arrhythmias in adult patients.

GNH USA supplies Lanoxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and transplant centres worldwide, adhering to EU GMP standards and providing reliable cold‑chain logistics for this injectable product.

Lanoxin (digoxin) acts on the cardiac conduction system and myocardial contractility to manage specific cardiovascular conditions.

Heart failure: improves cardiac output and reduces symptoms of congestion. Atrial fibrillation: slows ventricular rate and may help restore sinus rhythm. Atrial flutter: assists in rate control and symptom relief.

Digoxin may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Nausea - Fatigue - Blurred vision

Serious or Rare Side Effects: - Cardiac arrhythmias (including ventricular tachycardia) - Severe bradycardia or heart block - Visual disturbances (yellow‑green halos)

When using Lanoxin, clinicians should consider several safety factors.

Renal impairment: adjust dose and monitor serum digoxin levels. Electrolyte disturbances: correct potassium and magnesium before therapy. Thyroid disease: monitor thyroid function as digoxin may affect it. Pregnancy: use only if benefit outweighs risk; safety category unknown. Elderly patients: start with lower dose and observe for toxicity. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Digoxin interacts with several medicines; awareness of interaction severity guides management.

Major Interactions (Avoid): - Amiodarone: markedly increases digoxin serum concentration. - Quinidine: potentiates digoxin effect and risk of toxicity. - Verapamil: enhances digoxin levels and may cause bradyarrhythmias.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., furosemide): may cause electrolyte shifts affecting digoxin. - ACE inhibitors (e.g., enalapril): can increase digoxin levels. - Antibiotics (e.g., erythromycin, clarithromycin): may raise digoxin concentrations.